Iron Deficiency in Children: 40% Worldwide at Risk for Brain Development Issues

Nearly 40% of Young Children Worldwide Are Iron Deficient — and Their Brains May Pay the Price

Nearly 40% of children aged 6 to 59 months globally are iron deficient, according to estimates cited in a new systematic review protocol registered with PROSPERO by researchers at the Indian Council of Medical Research (ICMR). That number matters because iron is not just a blood nutrient. Between birth and age three, a child’s brain uses iron to build myelin — the fatty insulation around nerve fibres that determines how fast and reliably brain signals travel.

Scientists at the ICMR National Institute of Child Health and Development Research in New Delhi, led by Dr. A. Sinha, have now published a protocol for a systematic review that will examine whether iron supplementation during pregnancy or the first three years of life measurably improves brain myelination and neurodevelopmental outcomes. The protocol, published in Frontiers in Pediatrics in 2026, reflects a shift in how researchers think about child brain development nutrition: beyond haemoglobin and anaemia, toward direct measurements of the growing brain itself.

Why Iron Is a Brain Nutrient First, a Blood Nutrient Second

Most parents encounter iron through anaemia screening at paediatric check-ups. But iron’s role in the brain runs deeper. The ICMR team highlights three specific functions iron performs during early neurodevelopment:

• Myelination: Iron is required to synthesise the lipids and proteins that form myelin sheaths around axons. Myelination accelerates dramatically in the first two years of life.
• Neurotransmitter synthesis: Iron-dependent enzymes produce dopamine, noradrenaline and serotonin — chemicals that govern attention, mood and motivation.
• Energy metabolism: The developing brain consumes enormous amounts of energy, and iron is a cofactor in mitochondrial energy production.

The Critical Window: Why Timing Matters More Than Amount

Brain development proceeds through sensitive periods during which specific structures mature. Myelination peaks during the first 1,000 days of life — the same window covered by our guide to first 1,000 days nutrition. Iron deficiency during this window may impair cognitive, motor and behavioural outcomes, and the ICMR authors note a sobering possibility supported by earlier animal and human work: the brain may not fully recover once the deficit is corrected later.

White matter — the myelinated tissue — continues developing into early adulthood, but the foundations are laid before age three. This is why researchers increasingly treat infant iron status as a neurodevelopment variable, not merely a haematology one. Similar logic applies to other nutrients; DHA omega-3, for example, makes up roughly 40% of brain fatty acids during the same period.

What the New Systematic Review Will Examine

The ICMR protocol stands out for its scope and methodological rigour. It follows PRISMA 2020 guidelines and Cochrane Handbook recommendations, with pre-registered registration (PROSPERO ID: CRD420261388359).

Study Design and Outcomes

Reviewers will search seven databases — PubMed, Embase, Scopus, CENTRAL, PsycINFO, CINAHL and Web of Science — for randomised controlled trials, quasi-experimental studies, cohorts and observational studies. Interventions include iron supplementation in any form or dosage, given either to pregnant women or directly to children aged 0-3 years.

Primary outcomes fall into two categories:

• Neurodevelopmental measures: cognition, motor skills, language, executive function and memory, assessed with validated tools.
• Myelination measures: neuroimaging modalities such as MRI-based techniques that quantify white matter development directly.

Secondary outcomes include adverse events — an important inclusion, because iron supplementation carries real risks, including gastrointestinal effects and, in malaria-endemic regions, potential infection-related concerns. The team will assess risk of bias using ROB 2 and ROBINS-I, and rate certainty of evidence with GRADE.

Why a Protocol Matters

It is worth being precise: this is a review protocol, not final results. Publishing a protocol before conducting the review prevents selective reporting and lets readers evaluate the finished review against its stated plan. That transparency is what distinguishes a trustworthy synthesis from a cherry-picked one. The full evidence verdict on iron, myelination and neurodevelopment is still pending.

What Existing Evidence Already Shows

While the ICMR review has not yet reported, prior findings frame the question. Iron supplementation reliably improves haematological markers — haemoglobin and ferritin rise. But whether those blood improvements translate into better brain outcomes has been surprisingly hard to demonstrate, and results across trials have been inconsistent.

Part of the problem is measurement. Older trials relied on behavioural developmental tests, which are noisy and influenced by countless environmental factors. Neuroimaging changes the equation: if researchers can show supplementation increases myelination on MRI, that provides a biological mechanism connecting iron to measurable brain structure. This is precisely the gap the ICMR review aims to address by pairing neurodevelopmental tools with neuroimaging endpoints.

Who Is Most at Risk

The burden is not evenly distributed. Iron deficiency concentrates in low- and middle-income countries, where the ICMR authors note it is “highly prevalent,” but risk groups exist everywhere: preterm infants (who miss the third-trimester iron accumulation that typically accounts for most of a newborn’s iron stores), infants born small, exclusively breastfed infants after six months without iron-rich complementary foods, and toddlers with picky or low-meat diets. Maternal iron status during pregnancy also shapes fetal iron stores, which is why the review includes prenatal supplementation.

Practical Applications: What Parents Can Do Now

You do not need to wait for the completed review to act on well-established guidance.

Iron-Rich Foods by Age

1. 6-12 months: Iron-fortified infant cereal, pureed red meat, lentils. The American Academy of Paediatrics recommends introducing iron-containing foods as first complementary foods.
2. 12-24 months: Meat, poultry, fish, beans, spinach, fortified cereals — served alongside vitamin C sources (citrus, tomatoes) that boost non-haem iron absorption.
3. Limit interference: Cow’s milk in excess (over about 500 ml/day in toddlers) can displace iron-rich foods and irritate the gut, increasing loss.

Supplementation: Ask Before You Supplement

Iron is one nutrient where more is not better. Excess iron can cause toxicity and constipation, and routine supplementation in iron-replete children offers no established benefit. The right move is testing — typically a haemoglobin and ferritin check — before starting any supplement. Follow your paediatrician’s screening schedule, particularly around 9-12 months and again in the toddler years.

Think in Nutrient Systems, Not Single Nutrients

Iron works alongside other brain-building inputs: DHA for neuronal membranes (see our evidence-based guide to omega-3 DHA), adequate protein and energy, and protection from environmental toxins. Arsenic exposure in pregnancy, for instance, has been linked to lower IQ at age five — a reminder that neurodevelopment reflects the whole environment, not one nutrient in isolation.

Limitations and Open Questions

Honest framing requires acknowledging what remains unknown. Supplementation trials in infants face ethical and practical constraints; neuroimaging in healthy infants is expensive and rarely done at scale; and developmental outcomes in toddlers are difficult to measure reliably. Whether correcting iron deficiency after the sensitive window restores myelination fully — or only partially — remains one of the most consequential open questions in child brain development nutrition. The ICMR review is designed to bring the best available evidence to that question, but heterogeneity across studies may still limit firm conclusions.

Frequently Asked Questions

How common is iron deficiency in young children?

Roughly 40% of children aged 6 to 59 months worldwide are iron deficient, with the highest burden in low- and middle-income countries, according to estimates cited in the 2026 ICMR review protocol.

Does iron actually change brain structure, or just blood counts?

That is the open question. Iron is required for myelination, neurotransmitter synthesis and energy metabolism, but whether supplementation measurably improves myelination on neuroimaging is exactly what the ICMR systematic review will evaluate.

Should I give my toddler an iron supplement just in case?

No. Excess iron carries real risks, including toxicity. Ask your paediatrician for a haemoglobin and ferritin test first, and supplement only if levels indicate deficiency.

When is the most important window for iron in brain development?

The first 1,000 days — pregnancy through age two — when myelination peaks and the brain’s iron demand is highest. Deficiency during this period carries the greatest risk of lasting effects.

Key Takeaways

• Nearly 40% of children aged 6-59 months globally are iron deficient, making it one of the most common nutritional threats to early brain development.
• Iron builds brain myelin, synthesises neurotransmitters and powers neuronal energy metabolism — functions that peak during the first 1,000 days of life.
• A 2026 ICMR-led systematic review protocol will combine neurodevelopmental testing with neuroimaging to determine whether iron supplementation measurably improves myelination in children 0-3.
• Blood markers respond reliably to supplementation, but direct evidence linking supplements to better brain structure and function is still being established.
• Preterm infants, low-birthweight infants, and toddlers with low-iron diets face the highest deficiency risk.
• Test before supplementing: excess iron carries toxicity risks, so follow paediatric screening rather than supplementing preventively.
• Pair iron-rich foods with vitamin C, and limit excess cow’s milk in toddlers, which displaces iron intake.

This article is for informational purposes only. Consult a qualified professional for personalised advice.

---

Sources:
https://pubmed.ncbi.nlm.nih.gov/42712566/